I-Dapoxetine Hydrochloride CAS 129938-20-1 Assay ≥99.0% API Factory High Quality
Ubonelelo ngezoRhwebo iDapoxetine Hydrochloride kunye neMidiya eNxulumeneyo:
I-3-Chloropropiophenone CAS: 936-59-4
(S)-3-Amino-3-Phenylpropan-1-ol CAS: 82769-76-4
(S)-3-Amino-3-Phenylpropanoic Acid CAS: 40856-44-8
(R)-Diphenylprolinol CAS: 22348-32-9
(S)-Diphenylprolinol CAS: 112068-01-6
(S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS: 100306-34-1
I-Dapoxetine Hydrochloride CAS: 129938-20-1
Igama leMchiza | I-Dapoxetine Hydrochloride |
Izithethantonye | I-Dapoxetine HCl;I-LY-210448 Hydrochloride;Ipriligy;(S)-N,N-Dimethyl-3-(1-naphthyloxy)-1-phenylpropylamine Hydrochloride |
Inombolo yeCAS | 129938-20-1 |
Inombolo yeCAT | RF-API92 |
Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram |
Ifomula yeemolekyuli | C21H23NO·HCl |
Ubunzima beMolekyuli | 341.88 |
Ubushushu boGcino | Ubushushu beGumbi |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya Phantse uMhlophe Umgubo weCrystalline |
Ukuchongwa | IR |
Isivavanyi | ≥99.0% |
Indawo yokunyibilika | 175.0 ~ 182.0℃ |
Ilahleko ekomisweni | ≤1.0% |
Intsalela kwi-Ignition | ≤0.10% |
Ukujikeleziswa okuthe ngqo | +126.0°~130.0°(C=1, CH3OH) |
Iintsimbi ezinzima | ≤10ppm |
Ukungcola kweChromatographic | |
Ukungacoceki Okukodwa | ≤0.20% |
Ukungcola ngokupheleleyo | ≤1.0% |
Izinyibilikisi ezishiyekileyo | Iyahlangabezana neMfuneko |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | I-API, i-SSRI Inhibitor yonyango lwe-Ejaculation ngaphambi kwexesha (PE) kuMadoda |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Dapoxetine Hydrochloride (i-CAS 129938-20-1) yonyango lokuqala, inoveli emfutshane ekhethiweyo ekhethiweyo ye-serotonin reuptake inhibitor (SSRI) ethengiswa unyango lwe-ejaculation ngaphambi kwexesha kumadoda18-64 ubudala.I-ejaculation yangaphambi kwexesha (PE) yeyona nto ixhaphakileyo yokuphazamiseka ngokwesondo kwamadoda, kuqikelelwa ukuba ichaphazele ukuya kuthi ga kwi-30% yamadoda.Unyango lwe-Dapoxetine ngokuqhelekileyo lwalunyamezelwa kakuhle, kunye neziganeko eziphantsi ze-discontinuation syndrome, ukungasebenzi ngokwesondo, kunye neempawu zengqondo eziphuma kunyango.I-Dapoxetine isebenza ngokuvimbela umthuthi we-serotonin, ukwandisa isenzo se-serotonin kwi-post synaptic cleft, kwaye ngenxa yoko ukukhuthaza ukulibaziseka kwe-ejaculatory.Njengelungu lentsapho ekhethiweyo ye-serotonin reuptake inhibitor (SSRI), i-dapoxetine yadalwa ekuqaleni njenge-antidepressant.Nangona kunjalo, ngokungafaniyo nezinye ii-SSRIs, i-dapoxetine ifakwe kwaye ikhutshwe ngokukhawuleza emzimbeni.Ipropathi yayo esebenza ngokukhawuleza yenza ukuba ilungele unyango lwe-PE kodwa kungekhona njenge-antidepressant.